Close

ContraVir Pharma (CTRV) Reports Resignation of John Sullivan-Bolyai MD, MPH from Chief Medical Officer Position

December 29, 2017 4:03 PM EST Send to a Friend
ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV), announced today that John Sullivan-Bolyai will step down as Chief Medical Officer and take on ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login